HDAC/BET-IN-1 displays submicromolar inhibitory activity against HDAC1 and 6 ( IC 50 = 0.163 μM and 0.067 μM), and BRD4 ( K i = 0.076 μM), and possess potent antileukemia activity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HDAC
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.